Imara Inc. (IMRA): Price and Financial Metrics

Imara Inc. (IMRA): $4.62

0.12 (+2.67%)

POWR Rating

Component Grades













Add IMRA to Watchlist
Sign Up

Industry: Biotech



in industry

IMRA Stock Price Chart Interactive Chart >

Price chart for IMRA

IMRA Price/Volume Stats

Current price $4.62 52-week high $5.26
Prev. close $4.50 52-week low $0.97
Day low $4.46 Volume 42,314
Day high $4.69 Avg. volume 170,631
50-day MA $4.23 Dividend yield N/A
200-day MA $2.49 Market Cap 121.45M

Imara Inc. (IMRA) Company Bio

Imara, Inc. engages in the development and commercialization of novel therapeutics to treat patients suffering from hemoglobinopathies. Its product candidate, IMR-687 is a highly selective and small molecule inhibitor of PDE9. The company was founded by James G. McArthur in 2016 and is headquartered in Cambridge, MA.

IMRA Latest News Stream

Event/Time News Detail
Loading, please wait...

IMRA Latest Social Stream

Loading social stream, please wait...

View Full IMRA Social Stream

Latest IMRA News From Around the Web

Below are the latest news stories about IMARA INC that investors may wish to consider to help them evaluate IMRA as an investment opportunity.

Imara 10% Owner Trades $336K In Company Stock

RA CAPITAL MANAGEMENT, L.P. , 10% Owner at Imara (NASDAQ: IMRA ), reported a large insider buy on October 24, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that L.P. purchased 85,902 shares of Imara. The total transaction amounted to $336,811. Imara shares are trading up 2.75% at $4.64 at the time of this writing on Tuesday morning. Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm. Why Insider Transactions Are Important Insider transactions shouldn''t be used primarily to make … Full story available on

Benzinga | October 25, 2022

At What Point In Time Would I Choose To Purchase IMARA Inc. (NASDAQ: IMRA) Stock?

The trading price of IMARA Inc. (NASDAQ:IMRA) closed higher on Monday, October 24, closing at $4.52, 15.31% higher than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $3.86 and $4.76. In examining the 52-week price action we see that the stock hit a 52-week high … At What Point In Time Would I Choose To Purchase IMARA Inc. (NASDAQ: IMRA) Stock? Read More »

Stocks Register | October 25, 2022

Dow Rises 1.5%; Nasdaq Jumps Over 100 Points

U.S. stocks traded higher toward the end of trading, with the Dow Jones surging more than 450 points on Monday. The Dow traded up 1.50% to 31,547.65 while the NASDAQ rose 1.04% to 10,972.47. The S&P 500 also rose, gaining, 1.38% to 3,804.48. Also check this: Market Volatility Decreases As Dow Jumps More Than 700 Points Leading and Lagging Sectors Health care shares climbed 2.1% on Monday. Leading the sector was strength from Vaxcyte, Inc. (NASDAQ: PCVX ) and IMARA Inc. (NASDAQ: IMRA ). In trading on Monday, materials shares fell by 0.3%. Top Headline The S&P Global manufacturing PMI dropped to 49.9 in October from 52 in September, down from market estimates of 51. US services PMI fell to 46.6 in October from 49.3 in the prior month. Equities Trading UP Vaxcyte, Inc. (NASDAQ: PCVX ) shar...

Benzinga | October 24, 2022


NEW YORK, Oct. 20, 2022 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Imara Inc. (NASDAQ: IMRA)''s merger with…

PR Newswire | October 20, 2022

Struggling blood disorder biotech shuts down via reverse merger

Imara Inc., the blood disorder-focused company that earlier this year cut its staff to just six people, will be no more following a reverse merger with a Colorado biotech.

Yahoo | October 17, 2022

Read More 'IMRA' Stories Here

IMRA Price Returns

1-mo 12.96%
3-mo 7.69%
6-mo 278.69%
1-year 232.37%
3-year N/A
5-year N/A
YTD 12.96%
2022 81.78%
2021 -89.80%
2020 N/A
2019 N/A
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6489 seconds.